ライフサイエンスコーパス: testing

1 calculated for each woman-year in care with testing.

2 ith a commercial product used for diagnostic testing.

3 tic risk evaluation, counseling, and genetic testing.

4 ly accessibility of large-scale nucleic acid testing.

5 sed by chi-square, Mann-Whitney U, and ANOVA testing.

6 exhibiting stable properties over months of testing.

7 ous dose and the sensitivity of nucleic acid testing.

8 her phenotypes after correcting for multiple testing.

9 ed significant after correction for multiple testing.

10 es selected for bacteriophage susceptibility testing.

11 had a 71% agreement with drug susceptibility testing.

12 identify positive cases missed by molecular testing.

13 already restricting the provision of genetic testing.

14 27 schizophrenia patients who underwent ASSR testing.

15 or atypical hyperplasia (AH) were offered LS testing.

16 their substudy assignment upon completion of testing.

17 rwent evaluation for uveitis including QFT-G testing.

18 ion, distribution, metabolism, and excretion testing.

19 COVID-19 illness may not have had SARS-CoV-2 testing.

20 ate, as independently validated by secondary testing.

21 med by a positive skin biopsy and/or genetic testing.

22 offer telephone counseling and mailed saliva testing.

23 ate cancer in general practice on future PSA testing.

24 usted for covariates and multiple hypothesis testing.

25 thod fitness-for-purpose of rapid compliance testing.

26 domly selected for training, leaving 30% for testing.

27 r SARS-CoV-2 polymerase chain reaction (PCR) testing.

28 o low likelihood of CAD, who need no further testing.

29 nspecific, the diagnosis requires laboratory testing.

30 sults comparable to those found by in-clinic testing.

31 nd practical preclinical in vivo therapeutic testing.

32 -CoV-2, vaccine development, and therapeutic testing.

33 re was performed as part of standard-of-care testing.

34 involves a substantial amount of hypothesis testing.

35 F cryptococcal antigen or by repeat ME panel testing.

36 ng recommendation for baseline serum calcium testing, 13 conditional recommendations, and 1 best prac

37 sensitivity reaction rate after allergy skin testing (17%; 95% CI: 7%, 29%; zero of 21 studies) did n

38 s, 27 (56%) were asymptomatic at the time of testing; 24 subsequently developed symptoms (median time

39 Among those completing testing, 27 (41%) carried the familial pathogenic varian

40 of Lyme disease patients than the two-tiered testing (82.4% vs 70.6% in the training set, 66.7% vs 60

41 n that this strategy can be readily used for testing a greater number of sites with a broad dynamic r

42 utions to expand screening, and (iv) whether testing a large percentage of the population is feasible

43 Here, testing a large sample (N = 72) using an established par

44 here is significant variability in access to testing across the UK.

45 age 18-24 months that were negative upon re-testing after age 24 months, possibly indicating waning

46 eliable method for fosfomycin susceptibility testing against P. aeruginosa and stress the need for P.

47 The testing algorithm resulted in 34 GDH(+)/toxin(+), 53 GDH

48 stribution to create an efficient hypothesis testing algorithm that identifies biomarkers' main effec

49 The diagnostic monocular VF testing algorithm was comparable to standard automated p

50 d to guideline recommendations for multistep testing algorithms.

51 e testing panels, and antibiotic sensitivity testing all lead to different policy options for genomic

52 ospectively performed nationwide plasma CrAg testing among ART-experienced Ugandan adults with virolo

53 For vaccine testing, an easily accessible cell platform would be des

54 onavirus disease 2019 (COVID-19) serological testing and antiviral screening.

55 P = .01), though collinearity between viral testing and clinical service limited our ability to sepa

56 Lack of access to testing and concern regarding suboptimal PPE are common

57 onward transmission and show that intensive testing and contact tracing could have prevented SARS-Co

58 of COVID-19 and enable prioritization of PCR testing and containment efforts.

59 Sequence Analysis Pipeline using Statistical testing and Machine Learning (ASAP-SML), to identify fea

60 We used behavioral testing and morphological methods to detail the progress

61 recommendations on how to best implement MRD testing and MRD-directed therapy after allo-HCT are lack

62 We utilized sequence kernel association testing and polygenic risk score (PRS) methods to examin

63 oV-2 vaccine candidates could accelerate the testing and potential rollout of efficacious vaccines.

64 Novel drug development, testing and progression to clinical trials is overwhelmi

65 including natural enemy selection, efficacy testing and quantification of non-target impacts.

66 Testing and rejection of noncognate TCs on a sub-ms time

67 We report on the extent of testing and test results during the month of March in Ne

68 A one-time LTBI testing and treatment intervention among non-U.S.-born r

69 3) family history, (4) diagnostic phenotypic testing, and (5) variant correlation-through which a cli

70 RS-CoV-2 testing, well-child visits, HbA(1c) testing, and cancer screening.

71 USs, topics covered before and after genetic testing, and clinical recommendations using a hypothetic

72 on positively correlated with phenotypic AMR testing, and resistance to empirical antimicrobials was

73 socioeconomic inequalities in uptake of HIV testing, and to establish trends in testing uptake in th

74 Ongoing trials are testing antiviral therapies, immune modulators, and anti

75 Using a training-testing approach, epigenome-wide CpGs associated with as

76 manufacturing (3D printing) and experimental testing are implemented to justify the evaluation of the

77 (3)-the canonical video game environment for testing artificial intelligence techniques, in which mod

78 nts (61%) expressed high interest in genetic testing as a PLD: age >=35 years (adjusted odds ratio [a

79 The introduction of GIP testing as an assessment technique for GFD adherence may

80 Using culture-based testing as the standard, the negative predictive value o

81 ould increase the availability of SARS-CoV-2 testing as well as expand the settings in which this tes

82 ated, and reliable antibiotic susceptibility testing (AST) of bacterial pathogens is essential.

83 ication (ID) or antimicrobial susceptibility testing (AST), resulting in delayed therapeutic decision

84 eview of children with BSI and Verigene (VG) testing at a children's hospital.

85 Cervical screening involved HPV testing at age 35 years, or at ages 35 years and 45 year

86 y" has driven a shift in molecular biomarker testing away from local pathology laboratories and into

87 In contrast, in testing, B cell-intrinsic IRF-1 expression promoted the

88 iours, such as standing on 'safe' blocks and testing blocks prior to movement, increased when threat

89 of this approach for colistin susceptibility testing by assessing a large and diverse collection of r

90 ut the programme coverage area, at which HIV testing by certified testing service counsellors was one

91 tient reports, (iii) if specimen pooling and testing by research staff represent acceptable solutions

92 neuron targeting was pursued subsequently by testing C2C activity in the formalin inflammatory mouse

93 as well as expand the settings in which this testing can be performed.

94 ing about performance characteristics of HPV testing can be shifted to programme implementers and cut

95 Results of genetic testing can have a profound effect on clinical managemen

96 t the pig influenza model will be useful for testing candidate mAbs and emerging delivery platforms p

97 heir effort to achieve sufficient diagnostic testing capability for identifying infected individuals.

98 e specialized ordering pathways and adequate testing capacity can support continued organ transplanta

99 rast, the United States, hampered by limited testing capacity, has prioritized testing for specific g

100 g rate within 10-20 trials (under 1-2 min of testing), captured approximately 10% more variance in te

101 e controls were ascertained using pathologic testing, clinical examinations, and/or other tests.

102 hese data demonstrate that multicancer blood testing combined with PET-CT can be safely incorporated

103 e analogues, demonstrating the importance of testing compounds under physiologically relevant conditi

104 Testing conducted among 498 members of these case's hous

105 In vivo testing confirmed the selectivity of C(3)-ZIF(MCF) to ac

106 Serologic testing, contact-tracing, and next-generation sequencing

107 h the use of these methods, the cost of mass testing could be reduced by a large factor.

108 erformance significantly drops if applied to testing data sets from different European populations.

109 erformance in their corresponding population testing data sets, whereas their performance significant

110 only based on control data and in vitro drug testing data were not deployed during its calibration.

111 o reduce risk of future breast cancer, while testing DCIS for PgR is considered optional.

112 should be kept in mind when making platform testing decisions.

113 aset along with the scripts for training and testing deep learning methods.

114 le, during invasive cardiopulmonary exercise testing, demonstrates that that the right heart has enor

115 Although serologic testing does not provide information on the infectivity

116 Testing donors and recipients for HHV-8 is currently cha

117 Hence, individualized multi-variant ctDNA testing during and after NAC prior to surgery has progno

118 s/mL) using leftover plasma after viral load testing during September 2017-January 2018.

119 Comorbid conditions at time of LTBI testing (e.g., HIV, diabetes, chronic kidney disease, et

120 atment interventions, including enhanced HIV testing, earlier antiretroviral therapy (ART), and stren

121 his phenomenon (sometimes referred to as the testing effect or as retrieval-based learning) and consi

122 ne history, physical examination, laboratory testing, electrocardiography, and plain x-ray imaging ma

123 onger time scales, larger actions, and blind testing, enabling more of biology's stories to be told i

124 an Committee on Antimicrobial Susceptibility Testing (EUCAST) breakpoints and investigational (resear

125 monitoring schemes to the current viral load testing every 6 months and every 12 months.

126 ts were submitted to genome-wide association testing, followed by polygenic risk scoring and phenome-

127 Multiple testing following the Benjamini-Hochberg false discovery

128 WHO's call for universal drug susceptibility testing for all patients being evaluated for tuberculosi

129 Although guidelines recommend BRCA testing for all women with non-mucinous epithelial ovari

130 r improved stewardship related to diagnostic testing for and treatment of IFIs.

131 ovarian cancer should have germline genetic testing for BRCA1/2 and other ovarian cancer susceptibil

132 ospitalized for new-onset HF did not receive testing for CAD either during the hospitalization or in

133 In 2019, testing for chlamydia and gonorrhea occurred in 2.3% of

134 Preliminary bench testing for comparison of the Callascope camera to a $20

135 roughs, and evaluates whether differences in testing for coronavirus disease 2019 (COVID-19), hospita

136 e disequilibrium (LD) score-based enrichment testing for each trait.

137 Genetic testing for hereditary predisposition to cancer is warra

138 regnant women hospitalized with ARFI who had testing for influenza viruses by reverse-transcription p

139 transplantation, or as a result of germline testing for inherited variants.

140 ls were tested per experiment, with separate testing for male and female flies.

141 Introducing mandatory VEGF testing for patients with acquired demyelinating neuropa

142 The BAT outperformed sIgE testing for peanut or hazelnut and was comparable for wa

143 t data have investigated rates of diagnostic testing for pulmonary embolism (PE) in US emergency depa

144 by limited testing capacity, has prioritized testing for specific groups of persons.

145 ), a recent contact (OR, 2.3; P = 0.02), and testing for surveillance (OR, 2.7; P = 0.005) had higher

146 ve as a human-specific alternative to animal testing for the study of BM pathophysiology.

147 Contact mechanics testing further confirmed that the Young's modulus of th

148 For the testing group, sensitivity of the highest-performing (ba

149 esting when making such impactful changes in testing guidance.

150 Genetic testing has become an integral component of the diagnost

151 y tested due to the prespecified statistical testing hierarchy.

152 croscopically free of disease, but molecular testing identified the same T-cell receptor gamma rearra

153 and sustainability of PCR based surveillance testing in areas with receding and consistently low comm

154 aking advantage of the program of blood lead testing in Arizona, condor blood samples from 2008 to 20

155 ings, we envisage a broader role for genetic testing in DCM.

156 ing antiarrhythmic strategy warrants further testing in experimental models to evaluate its clinical

157 and then the association between colorectal testing in family physicians and their patients was exam

158 spectively obtained brain MRIs and cognitive testing in healthy controls and children with SCD.

159 different isotypes, and the use of antibody testing in identification of acutely ill patients or in

160 aster regulator genes followed by validation testing in independent children with severe asthma (n =

161 We investigated the value of susceptibility testing in predicting response in AIDS-associated crypto

162 ardiovascular risk in CKD, but this requires testing in prospective randomised trials.

163 Cognitive scientists have ramped up online testing in response to the COVID-19 pandemic.

164 forts to implement ultrasensitive resistance testing in routine settings.

165 ture and highlight the importance of genetic testing in the relevant clinical context of electrophysi

166 D(pos) patients during the week prior to PCR testing, in addition to anosmia/dysgeusia, constitutes t

167 Recent CT and GC incidence and testing increased among PLWH; however, only half of MSM

168 eedle Aspiration Biopsy Diagnosis, Molecular Testing, Indications, Extent and Outcomes of Surgery, Pr

169 ied all viruses detected by routine clinical testing (influenza A [n = 3], human metapneumovirus [n =

170 Here, we highlight key studies testing intrinsic and extrinsic hypotheses about geograp

171 POC testing is a promising strategy to cost-effectively impr

172 Conclusions Genetic testing is helpful in the diagnosis of HCM mimics in pat

173 Food allergy testing is not recommended in the routine evaluation of

174 In addition, testing is recommended for asymptomatic individuals with

175 Our recommendation for SARS-CoV-2 diagnostic testing is to select an assay with high sensitivity and

176 MBI result may be valid but requires further testing.Keywords: Breast, Molecular Imaging-Cancer(C) RS

177 findings suggest scaling up recommended HIV testing, linkage, and retention interventions can help r

178 For testing M3C, we developed clusterlab, a new method for s

179 Urine-based hrHPV testing may be a promising approach to improve cervical

180 vention and control measures including staff testing may help prevent hospitals from becoming indepen

181 Genetic testing may inform prevention, diagnosis, and treatment

182 ent level and that the quality of laboratory testing may vary between countries.

183 % considered susceptible, dependent upon the testing method used.

184 or mNGS technology and other hypothesis-free testing methodologies that are in development.

185 Our study initially employed point-of-care testing methods but this resulted in a high number of fa

186 Authenticity testing methods can be used to confirm whether labelled

187 eakpoints, the SC develops and validates new testing methods, provides guidance on how results should

188 ll defined by the conventional mCIM and eCIM testing methods; additional modifications appear require

189 sing mechanical/thermal quantitative sensory testing (MQST or TQST), were performed at the metatarsus

190 developed method is applicable for stability testing, multivitamin products shelf-life determination

191 tcomes beyond mortality may be important for testing new treatments.

192 ht the crucial role of a 3-D environment for testing NK cell function.

193 entification of each disease when diagnostic testing occurs either simultaneously or sequentially in

194 Further testing of 34 of these 36 signals in the CHARGE and Spir

195 n cases versus controls, rare variant burden testing of 56 genes revealed enrichment in MYH6 (P=0.000

196 Experimental testing of 62 screening candidates yielded the discovery

197 In vivo pharmacokinetic testing of 90 in rats revealed that the 5-amino-1,3,4-ox

198 we demonstrated the development and clinical testing of a disposable, multiplexed sensing device (ToM

199 d seronegative health care workers attending testing of asymptomatic and symptomatic staff at Oxford

200 Routine EV/PeV RT-PCR testing of cerebrospinal fluid (CSF) samples in children

201 n order to make feasible the development and testing of co-therapies with antibiotics that would incr

202 n, several companies have recently initiated testing of direct NLRP3 inhibitors in the clinic.

203 Testing of ductal carcinoma in situ (DCIS) for ER is rec

204 biomimetic, human bone platform for advanced testing of implants in vitro, and demonstrate the scient

205 Active testing of initial case's households enabled estimation

206 ulence and antibiotic resistance may require testing of multiple deep specimens.

207 l cavity structures and for the experimental testing of nasal function.

208 Alongside efficacy testing of novel therapies, effects on pulmonary patholo

209 As a result of the testing of raw and cooked meat products, it was shown th

210 using mycobacterial culture or Xpert MTB/RIF testing of sputum, urine, or blood.

211 The data presented here support testing of the efficacy of remdesivir treatment in the c

212 s on pathogen identification that lack rapid testing of the patient immune response, impeding clinici

213 Following pre-testing of the survey instrument in a different district

214 Testing of vaccine candidates to prevent infection with

215 Viral testing on day 0 was associated with lower risk of antib

216 the influence of automated visual field (VF) testing on intraocular pressure (IOP) in patients with o

217 re we demonstrate that sequential hypothesis testing on the same dataset by multiple researchers can

218 Current diagnostic testing only partially predicts this clinical heterogene

219 st of genes before conducting any hypothesis testing or experimental verification.

220 tes that were resistant by either phenotypic testing or sequencing, 78.6% (95% CI 76.1%-80.9%) had re

221 ogies to imaging, newborn screening, routine testing panels, and antibiotic sensitivity testing all l

222 y among patients of high-testing physicians (testing performed in >= 75% of their patients) compared

223 Testing performed using 45 reps on longitudinal plasma s

224 n this work is ranked at second place in the testing phase of the 2019 CPM-RadPath global challenge.

225 primary and secondary prevention, laboratory testing, physical activity, and nutrition.

226 n 90 days of biometry among patients of high-testing physicians (testing performed in >= 75% of their

227 heir patients) compared with patients of low-testing physicians.

228 niversal sensors applicable to point-of-care testing (POCT) have not yet been developed.

229 on of both asymptomatic and symptomatic HCWs testing positive for SARS-CoV-2 rapidly declined to near

230 bid conditions, and documented symptoms with testing positive for SARS-CoV-2.

231 ssfully, 221 (13%) underwent endoscopy after testing positive for TFF3 and 131 (8%, corresponding to

232 ANA negative at screening despite previously testing positive.

233 Testing potential therapies in clinical trials is hamper

234 the hACE2 mouse would be a valuable tool for testing potential vaccines and therapeutics.

235 Strengthening of testing programs and treatment support, along with preve

236 was compared to traditional rapid diagnostic testing (RDT) for the improved detection of infections a

237 as an enzyme stabilizer, and the shelf-life testing result shows that enzyme activity can be maintai

238 In the postanalytical stage, testing results should be carefully interpreted using bo

239 the role of viral screening and serological testing, return-to-work considerations for exposed or in

240 ude clinical diagnostic criteria and genetic testing; risk restratification strategies; LDL-cholester

241 cally used to recommend individuals for BRCA testing: self-reported Jewish ancestry and family histor

242 rage area, at which HIV testing by certified testing service counsellors was one of the health servic

243 were split into a training set (n=290) and a testing set (n=145), balancing for event and treatment g

244 We divided the sample into a training and a testing set and used machine-learning algorithms to clas

245 n the observed and predicted outcomes in the testing set, and use that relationship to correct subseq

246 le validation into training, validation, and testing sets, respectively.

247 Quantitative sensory testing showed abnormal findings.

248 Testing showed complete degradation within 46 days, prov

249 gans on a chip for disease modeling and drug testing, shows great potential for revolutionizing the d

250 the number of subscribers to a commonly used testing site has grown to more than 10 million.

251 microbeams using an in situ thermomechanical testing stage.

252 fish cell lines to be utilized in integrated testing strategies.

253 We found that routine testing substantially reduces risk of outbreaks, but may

254 nce from trial to trial, offering a means of testing the causal relationship between network activity

255 ative results on a randomized clinical trial testing the combination of apremilast, a phosphodiestera

256 ting germline-free zebrafish Danio rerio and testing the effect of the presence and absence of the ge

257 ized controlled trial was primarily aimed at testing the efficacy of ARP as compared with unassisted

258 We addressed this issue by testing the hypothesis that the primate amygdala acts, i

259 If fewer Earth-like exoplanets are observed, testing the HZ hypothesis from this relationship could b

260 Following face validity and pilot testing, the Test-Retest Reliability in a sample of 145

261 Typically, this is done via hypothesis testing: the statistical properties of the empirical tim

262 on small amounts of Leishmania donovani DNA, testing their ability to preserve specific genetic varia

263 ved by pooling (or combining) subsamples and testing them in groups(1-7).

264 n NF1 and provided preclinical platforms for testing therapies at each tumor grade.

265 As a first step in testing this hypothesis, we set out to demonstrate that

266 However, testing this is challenging because P varies within land

267 By testing three templates of different origin and sequence

268 se and moderate or severe ischemia on stress testing to be treated with an initial invasive strategy

269 went additional PCR- and immunohistochemical testing to define a sensitive ground truth of HP presenc

270 demonstrated, ranging from on-site skin care testing, to food safety to the most frequent in vitro di

271 This information can be used to guide testing, treatment, and public health prevention efforts

272 with a known test outcome, giving an overall testing uptake among 6062 eligible children of 60.0%.

273 e of HIV testing, and to establish trends in testing uptake in the past two decades.

274 artery disease underwent acute mental stress testing using a series of standardized speech/arithmetic

275 ance in prostate cancer amenable to clinical testing using available targeted therapies.

276 using the Liver Frailty Index and resilience testing using the Connor-Davidson Resilience Scale (CD-R

277 is who underwent outpatient physical frailty testing using the Liver Frailty Index and resilience tes

278 Equivalence testing, using study-specific smallest effect sizes of i

279 Experimental systems aimed at testing various sorts of memory are therefore also centr

280 alTrials.gov was searched to identify trials testing viral vaccines that had not advanced to phase 2

281 t closest to 5 years of age with optotype VA testing was 0.35 logarithm of the minimum angle of resol

282 Testing was accepted by index patients for 5326 (87.9%)

283 MMR-IHC with targeted MLH1-methylation testing was more discriminatory for LS than MSI with tar

284 ersion rate (negative to positive) on repeat testing was one percent.

285 Antifungal susceptibility testing was performed as outlined by Clinical and Labora

286 Testing was performed to confirm the presence of tick-bo

287 Spirometry testing was used to measure lung function and gene expre

288 March through May 2020, including SARS-CoV-2 testing, well-child visits, HbA(1c) testing, and cancer

289 onsult with primary stakeholders of COVID-19 testing when making such impactful changes in testing gu

290 Pairing HLA typing with COVID-19 testing where feasible could improve assessment of sever

291 ic variants were offered facilitated cascade testing whereby the genetics team identified and contact

292 ge, there are a paucity of long-term studies testing whether song is associated with age or longevity

293 ried blood spots (DBS)-based drug resistance testing, widely studied for HIV-1, has not been reported

294 de a number of scenarios for which serologic testing will play a role during our global response to t

295 ning the stevia's UGT, enables functionality testing with many substrates as well as other applicatio

296 Point-of-care (POC) testing with rapid turnaround times would allow more eff

297 ements, and allowing for products compliance testing with various national legislations on cannabinoi

298 ced HIV and access to both tests, concurrent testing with Xpert and LAM may be the best strategy for

299 ry for LS than MSI with targeted methylation testing, with 100% versus 56.3% (16/16 versus 9/16) sens

300 rican guidelines recommend repeat viral load testing within 6 months when human immunodeficiency viru